Tonix Pharmaceuticals Holding Corp Dividend Analysis

No. Tonix Pharmaceuticals Holding (TNXP) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold.

Through share buybacks rather than dividends. Over the last twelve months Tonix Pharmaceuticals Holding reduced its share count at a rate equivalent to a 15.7% buyback yield. A buyback returns value by shrinking the share count, so each remaining share owns more of the business, but unlike a dividend it pays you nothing in cash and can be stopped at any time without an announcement.

Not currently. Tonix Pharmaceuticals Holding's free cash flow is negative at -$158 million, meaning the business consumed cash over the period rather than generating it. A company funding a dividend from cash it is not producing would be paying shareholders out of its balance sheet or borrowings, which is not sustainable.

Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Tonix Pharmaceuticals Holding.